Implantable cardioverter-defibrillators may benefit certain younger patients with mild-moderate heart dysfunction: JAMA

An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- First reported by
- Business Medical Dialogues
- Reporter
- dr. kamal kant kohli
- Published
- Monday, 19 October 2026, 6:01 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.